Clinical trial NCT05036057: Turkish Version of the Individual Knowledge Statement Questionnaire of Chronic Obstructive Pulmonary Disease (COPD)
Official title: Investigation of the Psychometric Properties of the Turkish Version of the Individual Knowledge Statement Questionnaire of Chronic Obstructive Pulmonary Disease (COPD) Patient and Resident Proxies
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Chronic Obstructive Pulmonary Disease
Knowledge, Attitudes, Practice
Keywords: COPD
patient knowledge
proxies
Lead sponsor: Izmir Katip Celebi University
Sponsor class: OTHER
Collaborators: name: Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital
First posted: 2021-09-05
Enrollment: 340
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Study population will be patient with diagnosed COPD in the Chest Diseases Outpatient Clinic of Dr Suat Seren Chest Diseases and Surgery Training and Research Hospital, and their proxies.

Brief summary: The Individual Knowledge Statement Questionnaire of Chronic Obstructive Pulmonary Disease (COPD) Patient and Resident Proxies questionnaire, which can be used in patients with Chronic Obstructive Pulmonary Disease (COPD) and their relatives, will be adapted into Turkish and its psychometric properties will be examined, and the knowledge level of patients and their relatives about the disease and general health will be investigated.

Detailed description: The socio-demographic characteristics of the patients and their relatives will be obtained by asking to them by mutual interview method.

A disease-specific test, the COPD Assessment Test (CAT), will be used to assess patients' own health, and the St George Respiratory Questionnaire (SGRQ) will be used to assess patients' quality of life.

Comorbidities reported by the patient and their relatives will be filled in the Charlson Comorbidity Index. The dyspnea that patients encounter in their daily lives will be questioned with the Modified Medical Research Council (mMRC) Dyspnea Scale.

The "Individual Knowledge Statements of Patients and Resident Proxies" will be used for the individual information of the patient and their relatives about the disease and general health.

There is no control group in the study. SGRQ, CAT and numerical rating scale will be used for the validity of the Turkish version of Individual Knowledge Statements of Patients and Resident Proxies. For the test-retest, the evaluation will be done again after 15 days.

Eligibility criteria: Inclusion Criteria:

* Being 18 years or older
* Being diagnosed with COPD by a specialist physician (for patients)
* Being clinically stable (For patients, no history of hospital admission/hospitalization due to exacerbation in the last 4 weeks)
* Having information about the diagnosis (For patients)
* To read, write and understand Turkish
* Volunteering to participate in the study
* Being a proxy of the patient (living with the patient regardless of whether they are providing care or not)

Exclusion Criteria:

* Having musculoskeletal, neurological, cardiac, and/or cognitive problems other than COPD, which may create a caregiver burden for the patient's relative

Primary outcomes:
measure: Individual Knowledge Statement Questionnaire of Chronic Obstructive Pulmonary Disease (COPD)
timeFrame: Baseline
Secondary outcomes:
measure: COPD Assesment Test (CAT)
timeFrame: Baseline
measure: The modified Medical Research Council (mMRC) scale
timeFrame: Baseline
measure: Charlson Comorbidity Index
timeFrame: Baseline
measure: The St George's Respiratory Questionnaire (SGRQ)
timeFrame: Baseline
measure: Knowledge Score 0-10 Numerical Rating
timeFrame: Baseline
measure: The Sociodemographic Characteristics
timeFrame: Baseline
Other outcomes:
Locations:
Study officials:
References: